Digoxin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB504246527

Publication Date:

April 7, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Digoxin is a cardiac glycoside extracted from the leaves of the foxglove plant Digitalis lanata. Digoxin is used chronically in the therapy of cardiac arrhythmias, especially atrial fibrillation, atrial flutter and heart failure. It is the most effective medicine for the treatment of heart failure, and a third line medication in the treatment of irregular heartbeat. It is normally administered orally as tabs but can also be given intravenously under urgent circumstances.
The global market for Digoxin was estimated to be worth US$ 60 million in 2023 and is forecast to a readjusted size of US$ 74 million by 2030 with a CAGR of 3.1% during the forecast period 2024-2030
North America is the largest Digoxin market with about 37% market share. Asia-Pacific is follower, accounting for about 23% market share.The key players are C2 Pharma, Alkaloids Corporation, Vital Labs, Alchem etc. Top 3 companies occupied about 88% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Digoxin, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Digoxin by region & country, by Type, and by Application.
The Digoxin market size, estimations, and forecasts are provided in terms of sales volume (Kg) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Digoxin.
Market Segmentation
By Company
C2 Pharma
Alkaloids Corporation
Vital Labs
Alchem
Segment by Type:
Purity Above 98%
Purity Below 98%
Segment by Application
Tablet Product
Injection Product
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Digoxin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Digoxin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Digoxin in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Digoxin Product Introduction
1.2 Global Digoxin Market Size Forecast
1.2.1 Global Digoxin Sales Value (2019-2030)
1.2.2 Global Digoxin Sales Volume (2019-2030)
1.2.3 Global Digoxin Sales Price (2019-2030)
1.3 Digoxin Market Trends & Drivers
1.3.1 Digoxin Industry Trends
1.3.2 Digoxin Market Drivers & Opportunity
1.3.3 Digoxin Market Challenges
1.3.4 Digoxin Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Digoxin Players Revenue Ranking (2023)
2.2 Global Digoxin Revenue by Company (2019-2024)
2.3 Global Digoxin Players Sales Volume Ranking (2023)
2.4 Global Digoxin Sales Volume by Company Players (2019-2024)
2.5 Global Digoxin Average Price by Company (2019-2024)
2.6 Key Manufacturers Digoxin Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Digoxin Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Digoxin
2.9 Digoxin Market Competitive Analysis
2.9.1 Digoxin Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Digoxin Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Digoxin as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Purity Above 98%
3.1.2 Purity Below 98%
3.2 Global Digoxin Sales Value by Type
3.2.1 Global Digoxin Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Digoxin Sales Value, by Type (2019-2030)
3.2.3 Global Digoxin Sales Value, by Type (%) (2019-2030)
3.3 Global Digoxin Sales Volume by Type
3.3.1 Global Digoxin Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Digoxin Sales Volume, by Type (2019-2030)
3.3.3 Global Digoxin Sales Volume, by Type (%) (2019-2030)
3.4 Global Digoxin Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Tablet Product
4.1.2 Injection Product
4.2 Global Digoxin Sales Value by Application
4.2.1 Global Digoxin Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Digoxin Sales Value, by Application (2019-2030)
4.2.3 Global Digoxin Sales Value, by Application (%) (2019-2030)
4.3 Global Digoxin Sales Volume by Application
4.3.1 Global Digoxin Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Digoxin Sales Volume, by Application (2019-2030)
4.3.3 Global Digoxin Sales Volume, by Application (%) (2019-2030)
4.4 Global Digoxin Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Digoxin Sales Value by Region
5.1.1 Global Digoxin Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Digoxin Sales Value by Region (2019-2024)
5.1.3 Global Digoxin Sales Value by Region (2025-2030)
5.1.4 Global Digoxin Sales Value by Region (%), (2019-2030)
5.2 Global Digoxin Sales Volume by Region
5.2.1 Global Digoxin Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Digoxin Sales Volume by Region (2019-2024)
5.2.3 Global Digoxin Sales Volume by Region (2025-2030)
5.2.4 Global Digoxin Sales Volume by Region (%), (2019-2030)
5.3 Global Digoxin Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Digoxin Sales Value, 2019-2030
5.4.2 North America Digoxin Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Digoxin Sales Value, 2019-2030
5.5.2 Europe Digoxin Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Digoxin Sales Value, 2019-2030
5.6.2 Asia Pacific Digoxin Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Digoxin Sales Value, 2019-2030
5.7.2 South America Digoxin Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Digoxin Sales Value, 2019-2030
5.8.2 Middle East & Africa Digoxin Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Digoxin Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Digoxin Sales Value
6.2.1 Key Countries/Regions Digoxin Sales Value, 2019-2030
6.2.2 Key Countries/Regions Digoxin Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Digoxin Sales Value, 2019-2030
6.3.2 United States Digoxin Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Digoxin Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Digoxin Sales Value, 2019-2030
6.4.2 Europe Digoxin Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Digoxin Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Digoxin Sales Value, 2019-2030
6.5.2 China Digoxin Sales Value by Type (%), 2023 VS 2030
6.5.3 China Digoxin Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Digoxin Sales Value, 2019-2030
6.6.2 Japan Digoxin Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Digoxin Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Digoxin Sales Value, 2019-2030
6.7.2 South Korea Digoxin Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Digoxin Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Digoxin Sales Value, 2019-2030
6.8.2 Southeast Asia Digoxin Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Digoxin Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Digoxin Sales Value, 2019-2030
6.9.2 India Digoxin Sales Value by Type (%), 2023 VS 2030
6.9.3 India Digoxin Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 C2 Pharma
7.1.1 C2 Pharma Company Information
7.1.2 C2 Pharma Introduction and Business Overview
7.1.3 C2 Pharma Digoxin Sales, Revenue and Gross Margin (2019-2024)
7.1.4 C2 Pharma Digoxin Product Offerings
7.1.5 C2 Pharma Recent Development
7.2 Alkaloids Corporation
7.2.1 Alkaloids Corporation Company Information
7.2.2 Alkaloids Corporation Introduction and Business Overview
7.2.3 Alkaloids Corporation Digoxin Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Alkaloids Corporation Digoxin Product Offerings
7.2.5 Alkaloids Corporation Recent Development
7.3 Vital Labs
7.3.1 Vital Labs Company Information
7.3.2 Vital Labs Introduction and Business Overview
7.3.3 Vital Labs Digoxin Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Vital Labs Digoxin Product Offerings
7.3.5 Vital Labs Recent Development
7.4 Alchem
7.4.1 Alchem Company Information
7.4.2 Alchem Introduction and Business Overview
7.4.3 Alchem Digoxin Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Alchem Digoxin Product Offerings
7.4.5 Alchem Recent Development
8 Industry Chain Analysis
8.1 Digoxin Industrial Chain
8.2 Digoxin Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Digoxin Sales Model
8.5.2 Sales Channel
8.5.3 Digoxin Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

C2 Pharma
Alkaloids Corporation
Vital Labs
Alchem

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂